Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 25 member 45 (SLC25A45) is a predicted mitochondrial inner membrane transporter and a member of the SLC25 (mitochondrial carrier) family, which is responsible for the import and export of metabolites in the mitochondria[1][2][4][6][7]. Although the precise endogenous substrate of SLC25A45 remains unidentified, phylogenetic analysis places it within a clade of amino acid transporters, suggesting a potential role in transporting amino acids or related molecules across the mitochondrial inner membrane[2]. Expression studies indicate SLC25A45 is widely but modestly expressed in human tissues, with higher levels in testis, liver, and kidney, and lower expression in brain regions[6]. Functional studies in closely related family members point to a significant role for SLC25 carriers in mitochondrial metabolism, bioenergetics, and overall cellular metabolic regulation[2][4]. SLC25A45 itself remains poorly characterized, with no established pharmacological modulators, disease associations, or clinical interventions directly targeting it[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 45 (SLC25A45).